Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinoma

Within 5 years after percutaneous ablation of hepatocellular carcinoma, roughly 70% of patients experience tumor recurrence. Relapses beyond curative options affected patients’ survival. Ablation shares with resection common predictive factors of recurrence as size of the tumor, multinodularity and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hepat Oncol
Main Authors: Ganne-Carrié, Nathalie, Nault, Jean-Charles, Ziol, Marianne, N'Kontchou, Gisèle, Nahon, Pierre, Grando, Véronique, Bourcier, Valérie, Barge, Sandrine, Beaugrand, Michel, Trinchet, Jean-Claude, Seror, Olivier
Formato: Artigo
Idioma:Inglês
Publicado em: Future Medicine Ltd 2014
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6095149/
https://ncbi.nlm.nih.gov/pubmed/30190975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep.14.22
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados